During the past decade, Tokyo Teishin Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tokyo Teishin Hospital" #1 collaborator was "Incyte Corporation" with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Tokyo Teishin Hospital" are "Atopic Dermatitis" (3 trials), "Palmoplantar Pustulosis" (1 trials) and "Psoriasis" (1 trials). Many other conditions were trialed in "Tokyo Teishin Hospital" in a lesser frequency.

Most popular intervention types in "Tokyo Teishin Hospital" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Baricitinib" (3 trials), "Apremilast" (1 trials), "CP-690, 550" (1 trials) and "CP-690,550" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tokyo Teishin Hospital" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Tokyo Teishin Hospital". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Tokyo Teishin Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tokyo Teishin Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".